HARROW, INC. — Director's Dealing 2019

Feb 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2019-02-19

Reporting Person: SAHAREK JOHN P. (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-19	Option - Right to Buy	$6.30	A	50000	Acquired	2029-02-19	Common Stock (50000)	Direct
2019-02-19	Restricted Stock Unit	$0	A	50000	Acquired	2022-02-19	Common Stock (50000)	Direct

Footnotes

F1: Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan (the "Plan"). The stock options vest in equal quarterly installments over a three-year period.

F2: Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant.